Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: A case report

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 8, 2007, Pages 801-803

  Squizzato, Alessandro ^a,b,c   Vitale, Josè ^a   Gerdes, Victor E A ^b   Romualdi, Erica ^a   Büller, Harry R ^b   Ageno, Walter ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Anticoagulant therapy; Hyperthyroidism; Venous thromboembolism

Indexed keywords

ALFUZOSIN; AMILORIDE; ANTICOAGULANT AGENT; ANTIVITAMIN K; DIGOXIN; DUTASTERIDE; ENOXAPARIN; HYDROCHLOROTHIAZIDE; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; THIAMAZOLE; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; HUMAN; HYPERTHYROIDISM; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; ANTITHYROID AGENTS; HUMANS; HYPERTHYROIDISM; MALE; METHIMAZOLE; RECURRENCE; VENOUS THROMBOSIS; WARFARIN;

EID: 35848966337     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3282f09de2     Document Type: Article

References (11)

1. Palareti G, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, et al. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study. Thromb Haemost 1997; 78:1438-1443.
2. Ginsberg JA, Crowther MA, White RH, Ortel TL. Anticoagulation therapy. Hematol Am Soc Hematol Educ Program 2001; 1:339-357.
3. Erem C, Ersoz H, Karti SS, Ukinc K, Hacihasanoglu A, Deger O, et al. Blood coagulation and fibrinolysis in hyperthyroidism. J Endocrinol Invest 2002; 25:345-350.
4. Marongiu F, Conti M, Mameli G, Murtas ML, Balzano S, Sorano G, et al. Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 1988; 11:723-725.
5. Squizzato A, Gerdes VE, Brandjes DP, Buller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke 2005; 36:2302-2310.
6. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353:1167-1173.
7. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003; 138:128-134.
8. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, et al. Thyroid hormone receptor dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 2004; 145:2804-2814.
9. Graninger W, Pirich KR, Speiser W. Effect of thyroid hormones on plasma protein concentrations in man. J Clin Endocrinol Metab 1986; 63:407-411.
10. Rogers IIJS, Stanley RS. Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 1983; 102:444-449.
11. Morimoto S, Nemoto M, Han A, Katoh S, Kurata H, Utsunomiya K, et al. Economy class syndrome associated with diabetes and Graves disease. Nippon Naika Gakkai Zasshi 2003; 92:2020-2022.